What are alternatives to metformin for a 50-year-old male seeking fewer adverse effects?

Metformin alternatives for a 50-year-old male seeking fewer adverse effects include DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, sulfonylureas, and pioglitazone. The choice should consider the individual's adverse effect profile, additional health benefits, and personal treatment goals.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-15
DOI
https://doi.org/10.5281/zenodo.24259561
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What are alternatives to metformin for a 50-year-old male seeking fewer adverse effects?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Diabetes Treatment and Management
article

What are alternatives to metformin for a 50-year-old male seeking fewer adverse effects?

Tripdatabase
article en

Abstract

Metformin alternatives for a 50-year-old male seeking fewer adverse effects include DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, sulfonylureas, and pioglitazone. The choice should consider the individual's adverse effect profile, additional health benefits, and personal treatment goals.

Zenodo (CERN European Organization for Nuclear Research)
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
What are alternatives to metformin for a 50-year-old male seeking fewer adverse effects? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS